Add BrightSurf on Google Email

Interrupting Parkinson's disease

Researchers have identified a toxic cascade in Parkinson's disease and found that treating dopamine neurons with antioxidants early on may prevent degeneration and improve neuron function. The study also highlights the importance of studying human neurons to develop new therapies.

SourceNorthwestern University·JournalScience·DateSep 7, 2017

Hard choices? Ask your brain's dopamine

Researchers at Salk Institute find that changing dopamine levels can alter upcoming choices, suggesting new avenues for treating Parkinson's and OCD. The study uses advanced techniques to measure dopamine concentration in mice brains, revealing a tight association between brain chemistry and decision-making.

SourceSalk Institute·JournalNeuron·DateMar 9, 2017

How humans bond: The brain chemistry revealed

A new study by Northeastern University psychologist Lisa Feldman Barrett found that the neurotransmitter dopamine plays a crucial role in human bonding. The research, which used a novel technology to scan mothers' brains while interacting with their infants, showed that strong social relationships can improve outcomes for individuals w...

SourceNortheastern University·JournalProceedings of the National Academy of Sciences·DateFeb 17, 2017

Stimulation of dopamine neurons induces arousal of mice receiving general anesthesia

Researchers at Massachusetts General Hospital discovered that stimulating dopamine neurons in mice receiving general anesthesia triggers signs of arousal, including movement and increased respiratory rate. This finding could lead to the development of new therapies to treat conditions like traumatic brain injury and coma.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·DateOct 26, 2016

Targeting the gut-brain connection can impact immunity

A study by Duke University researchers found that manipulating dopamine signaling can control inflammation in the gut, providing a proof of principle for using drugs originally designed to target the nervous system to treat immune system disorders such as rheumatoid arthritis and autoimmune disease.

SourceDuke University·JournalCurrent Biology·DateAug 11, 2016

Schizophrenia simulator: When chemistry upends sanity's balance

The Georgia Institute of Technology researchers have created an interactive model of the brain's chemical balance to simulate major systemic changes in schizophrenia sufferers. This tool depicts chemical underpinnings in simple graphics, helping clinicians better understand the disease and test hypotheses virtually.

SourceGeorgia Institute of Technology·JournalBiochimica et Biophysica Acta (BBA) - General Subjects·DateAug 3, 2016

New clues about the aging brain's memory functions

A European study led by Umea University Professor Lars Nyberg found a positive link between the dopamine D2 receptor and long-term episodic memory, which often declines with age. The research suggests that impairment of the dopamine system may play a crucial role in understanding age-related cognitive decline.

SourceUmea University·JournalProceedings of the National Academy of Sciences·DateJun 29, 2016

Evolution meets biochemistry to better understand how dopamine receptors work

Baylor College of Medicine researchers have developed a new mathematical tool that combines biochemistry and computational analysis to identify specific structural changes in the dopamine 2 receptor, which helps maintain its structure and function throughout an evolutionary time scale. This discovery opens the possibility for better dr...

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateMar 16, 2016